வேட்டைக்காரன் மருத்துவ ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வேட்டைக்காரன் மருத்துவ ஆராய்ச்சி நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வேட்டைக்காரன் மருத்துவ ஆராய்ச்சி நிறுவனம் Today - Breaking & Trending Today

COVID Australia: What difference does it make when you get your second AstraZeneca jab?


Advertisement
State and federal health officials have asked older Sydneysiders who have had their first AstraZeneca jabs to come back early for a second dose in response to the circulation of the Delta variant of COVID-19. NSW Chief Health Officer Kerry Chant has said people should consider shortening the interval between first and second jabs from 12 weeks to six. “We might sacrifice a bit of long-term protection but we’re making sure you’re protected earlier and, at this time, that’s the strategy we’d suggest,” she said. The call was backed by Australia’s Chief Medical Officer, Paul Kelly – but only for people living in Greater Sydney. Why? ....

Nathan Bartlett , Hunter Medical Research Institute , University Of Newcastle , Associate Professor Nathan Bartlett , நாதன் பார்ட்லெட் , வேட்டைக்காரன் மருத்துவ ஆராய்ச்சி நிறுவனம் , பல்கலைக்கழகம் ஆஃப் நியூகேஸில் , இணை ப்ரொஃபெஸர் நாதன் பார்ட்லெட் ,

Hunter people to benefit from local research into dementia tests and treatments


University of Newcastle
Two exciting new research studies that will look to identify those most at risk of developing dementia and then attempt to delay or stop its development are underway in the Hunter New England region.
Dementia Study Patient in HMRI MRI with technician
Dementia is a debilitating disease which progressively robs people of their faculties and has been resistant to treatment. All that may be about to change with the development of several new drugs which may slow the progression of the disease and its symptoms.
Alzheimer’s disease, the most common type of dementia, has long been thought to involve the buildup in the brain of plaques. These plaques are made of a protein called beta amyloid and a new type of antibody therapy which can remove these proteins has shown promise in other studies. ....

Michael Breakspear , Australian Dementia Network Adnet , University Of Newcastle Dementia Study Patient , Hunter Medical Research Institute , Hunter New England Health , University Of Newcastle , Hunter New England , Study Patient , Dementia Study Patient , Australian Dementia Network , Professor Michael Breakspear , Systems Neuroscience , Professor Breakspear , Prospective Imaging Study , Calvary Mater Newcastle , வேட்டைக்காரன் மருத்துவ ஆராய்ச்சி நிறுவனம் , வேட்டைக்காரன் புதியது இங்கிலாந்து ஆரோக்கியம் , பல்கலைக்கழகம் ஆஃப் நியூகேஸில் , வேட்டைக்காரன் புதியது இங்கிலாந்து , ஆஸ்திரேலிய முதுமை வலைப்பின்னல் , அமைப்புகள் நரம்பியல் , கல்வாரி மேட்டர் நியூகேஸில் ,